Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-25 to 2023-01-26
Current total value of award: $32057.04
Description: 4559857476!REBLOZYL 75 MG VIALS